Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-043441
Filing Date
2022-04-07
Accepted
2022-04-07 08:13:45
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2210624d4_defa14a.htm DEFA14A 10238
2 GRAPHIC tm2210624d4_defa14aimg001.jpg GRAPHIC 351853
3 GRAPHIC tm2210624d4_defa14aimg002.jpg GRAPHIC 116674
  Complete submission text file 0001104659-22-043441.txt   657017
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-38247 | Film No.: 22812350
SIC: 2834 Pharmaceutical Preparations